메뉴 건너뛰기




Volumn 35, Issue 5, 2008, Pages 563-567

Opioids for Cancer Breakthrough Pain: A Pilot Study Reporting Patient Assessment of Time to Meaningful Pain Relief

Author keywords

Breakthrough pain; cancer; opioids; rescue medication

Indexed keywords

FENTANYL CITRATE; HYDROMORPHONE; METHADONE; MORPHINE; OPIATE; OXYCODONE;

EID: 43049104583     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2007.06.012     Document Type: Article
Times cited : (93)

References (11)
  • 1
    • 0032899247 scopus 로고    scopus 로고
    • Breakthrough pain: characteristics and impact in patients with cancer pain
    • Portenoy R.K., Payne D., and Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 81 (1999) 129-134
    • (1999) Pain , vol.81 , pp. 129-134
    • Portenoy, R.K.1    Payne, D.2    Jacobsen, P.3
  • 2
    • 0037247681 scopus 로고    scopus 로고
    • Description and predictors or direct and indirect costs of pain reported by cancer patients
    • Fortner B.V., Demarco G., Irving G., et al. Description and predictors or direct and indirect costs of pain reported by cancer patients. J Pain Symptom Manage 25 (2003) 9-18
    • (2003) J Pain Symptom Manage , vol.25 , pp. 9-18
    • Fortner, B.V.1    Demarco, G.2    Irving, G.3
  • 3
    • 2942637938 scopus 로고    scopus 로고
    • Breakthrough pain characteristics and syndromes in patients with cancer pain: an international survey
    • Caraceni A., Martini C., Zecca E., et al. Breakthrough pain characteristics and syndromes in patients with cancer pain: an international survey. Palliat Med 18 (2004) 177-183
    • (2004) Palliat Med , vol.18 , pp. 177-183
    • Caraceni, A.1    Martini, C.2    Zecca, E.3
  • 4
    • 21244467522 scopus 로고    scopus 로고
    • Consensus panel recommendations for the assessment and management of breakthrough pain. Part 2. Management
    • Bennett D., Burton A.W., Fishman S., et al. Consensus panel recommendations for the assessment and management of breakthrough pain. Part 2. Management. P & T 30 (2005) 354-361
    • (2005) P & T , vol.30 , pp. 354-361
    • Bennett, D.1    Burton, A.W.2    Fishman, S.3
  • 5
    • 0031881150 scopus 로고    scopus 로고
    • Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences
    • Ripamonti C., De Conno F., Groff L., et al. Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences. Ann Oncol 9 (1998) 79-83
    • (1998) Ann Oncol , vol.9 , pp. 79-83
    • Ripamonti, C.1    De Conno, F.2    Groff, L.3
  • 6
    • 43049104364 scopus 로고    scopus 로고
    • Assessment
    • Davies A. (Ed), Oxford University Press, Oxford
    • Laverty D., and Davies A. Assessment. In: Davies A. (Ed). Cancer-related breakthrough pain (2006), Oxford University Press, Oxford 23-30
    • (2006) Cancer-related breakthrough pain , pp. 23-30
    • Laverty, D.1    Davies, A.2
  • 7
    • 33750322229 scopus 로고    scopus 로고
    • A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer
    • Portenoy R., Taylor D., Messina J., and Tremmel L. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer. Clin J Pain 22 (2006) 805-811
    • (2006) Clin J Pain , vol.22 , pp. 805-811
    • Portenoy, R.1    Taylor, D.2    Messina, J.3    Tremmel, L.4
  • 8
    • 10344222128 scopus 로고    scopus 로고
    • Characterization of the early pharmacodynamic profile of oral methadone for cancer-related breakthrough pain: a pilot study
    • Fisher K., Stiles C., and Hagen N.A. Characterization of the early pharmacodynamic profile of oral methadone for cancer-related breakthrough pain: a pilot study. J Pain Symptom Manage 28 (2004) 619-625
    • (2004) J Pain Symptom Manage , vol.28 , pp. 619-625
    • Fisher, K.1    Stiles, C.2    Hagen, N.A.3
  • 9
    • 19944381491 scopus 로고    scopus 로고
    • Core outcome measures for chronic pain clinical trials: IMMPACT recommendations
    • Dworkin R.H., Turk D.C., Farrar J.T., et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113 (2005) 9-19
    • (2005) Pain , vol.113 , pp. 9-19
    • Dworkin, R.H.1    Turk, D.C.2    Farrar, J.T.3
  • 10
    • 33645518854 scopus 로고    scopus 로고
    • Opioids for the management of breakthrough (episodic) pain in cancer patients
    • 10.1002/14651858.CD004311.pub2 Issue 1. Art. No.: CD004311
    • Zeppetella G., and Ribeiro M.D.C. Opioids for the management of breakthrough (episodic) pain in cancer patients. The Cochrane Database of Systematic Reviews (2006) 10.1002/14651858.CD004311.pub2 Issue 1. Art. No.: CD004311
    • (2006) The Cochrane Database of Systematic Reviews
    • Zeppetella, G.1    Ribeiro, M.D.C.2
  • 11
    • 0037758126 scopus 로고    scopus 로고
    • Morphine and alternative opioids in cancer pain: the EAPC recommendations
    • Hanks G.W., De Conno F., Cherny N., et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84 (2001) 587-593
    • (2001) Br J Cancer , vol.84 , pp. 587-593
    • Hanks, G.W.1    De Conno, F.2    Cherny, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.